News
Kinnate Biopharma (NASDAQ:KNTE) develops small molecule kinase inhibitors to treat genomically defined cancers. The company has two molecules in the clinic, exarafenib and KIN-3248....
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
This article was written by Follow I’m a full time value investor and writer who enjoys using classical value ratios to pick my portfolio....
News
This article was written by Follow Buffett-style rational value picks | Top 95th percentile of financial bloggers according to TipRanks.Six years of long-horizon investment...
News
Footnote: 1. A composite is an aggregation of one or more portfolios into a single group that represents a particular investment objective or strategy....
News
Having a good investment philosophy matters as much as picking the “right” stocks. That’s because even dominant companies can fall on hard times due...
News
The next figure shows asset class performance for all of 2022 and year-to-date in 2023. The first part of the figure contains ACWI, a...
News
She doesn’t know how much her student-loan bill will be when the years-long pandemic-era freeze on payments ends. Eminger’s loans were transferred during the...
News
Here are three tips on how to approach early money conversations with a future partner, based on my own marriage and the experience of...
News
“If men liked shopping, they’d call it research.”― Cynthia Nelms Today, we take a deeper look at a well-known retailer. After a pullback, the...
News
Throughout my career, I’ve seen that an overabundance of personal finance instruction is available from a litany of sources. Some of the sources are...
News
This article is dedicated to our summer interns at iREIT on Alpha, who are all college students and eager to learn about dividend investing....
News
Introduction Huntington Ingalls Industries (NYSE:HII) is one of the few stocks I sold over the past three years. In this case, it was purely...
News
This article was first released to Systematic Income subscribers and free trials on May 14. Welcome to another installment of our CEF Market Weekly...
